{"id":34469,"date":"2023-03-30T18:04:42","date_gmt":"2023-03-30T13:04:42","guid":{"rendered":"http:\/\/myanmarnewsgazette.com\/?guid=c7d67a064c58474b11e8fee5b84d6356"},"modified":"2023-03-30T18:04:42","modified_gmt":"2023-03-30T13:04:42","slug":"citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure","status":"publish","type":"post","link":"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/","title":{"rendered":"Citeline Launches TrialScope Intelligence,\u00a0Meeting the Growing Complexities of Clinical Trial Disclosure"},"content":{"rendered":"
\n

NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) — Clinical trial disclosure compliance is challenging, whether a sponsor is registering five trials or 500 trials. Compounding the complexity is the fact that no global standards exist for disclosure. With ever-changing global regulations, new requirements on the rise and the threat of monetary penalties, study sponsors are feeling the pressure to maintain compliance, minimize risk and safeguard their brand reputation.<\/p>\n

Created for by disclosure experts for any professional overseeing the disclosure process in life sciences organizations \u2014 disclosure, regulatory affairs, ClinOps and others \u2014 Citeline\u2019s new TrialScope Intelligence platform is an all-in-one disclosure solution that centralizes the critical knowledge needed in clinical research for timely compliance with global clinical trial requirements. Citeline\u2019s portfolio of solutions and services covers all aspects of drug development: clinical, regulatory and commercial. TrialScope Intelligence complements Citeline\u2019s flagship regulatory solution, TrialScope Disclose, the industry\u2019s most widely used platform for clinical trial disclosure management.<\/p>\n

TrialScope Intelligence empowers compliance stakeholders to proactively plan trial disclosure throughout the clinical lifecycle. In an easily digestible format, it provides granular, country-specific requirements for close to 200 countries, English translations, disclosure trends and insights, all with intelligent, action-oriented functionalities.<\/p>\n

With TrialScope Intelligence, users regain hours previously spent searching, mining data for pertinent regulatory information, keeping up to date and monitoring trends. TrialScope Intelligence also enhances collaboration across teams and favors alignment with external parties.<\/p>\n

Just as parent company Norstella helps life sciences clients navigate each step of the drug development life cycle, Citeline\u2019s TrialScope Intelligence helps study sponsors navigate the complexities of clinical trial regulations.<\/p>\n

\u201cOur mission,\u201d said David Laky, Citeline\u2019s Clinical and Regulatory General Manager, \u201cis to help sponsors understand their regulatory requirements in advance of starting a clinical trial and reduce the risks of noncompliance by helping them sharpen their knowledge, strategize, plan out and manage timely clinical trial disclosures globally. With TrialScope Intelligence, sponsors know what, when, why and how they need to comply.\u201d He explained that each branch of the solution is validated along the way, with new branches to be added, as TrialScope Intelligence continually evolves post-launch. \u201cIt\u2019s an iterative cycle, and it\u2019s meant to never end.\u201d<\/p>\n

Clinical trial disclosure, in addition to meeting legal requirements, reflects sponsors\u2019 commitment to transparency. This translates to increased investor confidence, public trust, and patient participation in clinical trials.<\/p>\n

Learn more about TrialScope Intelligence<\/a>.<\/p>\n

About Citeline <\/strong>
\nCiteline, a
Norstella<\/a> company, powers a full suite of complementary business intelligence offerings to meet the evolving needs of life science professionals to accelerate the connection of treatments to patients and patients to treatments. These patient-focused solutions and services deliver and analyze data used to drive clinical, commercial, and regulatory-related decisions and create real-world opportunities for growth.<\/p>\n

Citeline\u2019s global teams of analysts, journalists and consultants keep their fingers on the pulse of the pharmaceutical, biomedical and medtech industries, covering it all with expert insights: key diseases, clinical trials, drug R&D and approvals, market forecasts and more. For more information on one of the world\u2019s most trusted health science partners, visit\u00a0Citeline<\/u><\/a>.<\/p>\n

Citeline PR contact:<\/strong>
\nDiffusion PR for Citeline
\n
citeline@diffusionpr.com<\/u><\/a>
\n(213) 318-4500<\/p>\n

GlobeNewswire Distribution ID 8795278<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) \u2014 Clinical trial disclosure compliance is challenging, whether a sponsor is registering five trials or 500 trials. Compounding the complexity is the fact that no global standards exist for disclosure. With ever-changing global regulations, new requirements on the rise and the threat of monetary penalties, study sponsors are [\u2026]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"yoast_head":"\nCiteline Launches TrialScope Intelligence,\u00a0Meeting the Growing Complexities of Clinical Trial Disclosure - Myanmar News Gazette<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Citeline Launches TrialScope Intelligence,\u00a0Meeting the Growing Complexities of Clinical Trial Disclosure - Myanmar News Gazette\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) \u2014 Clinical trial disclosure compliance is challenging, whether a sponsor is registering five trials or 500 trials. Compounding the complexity is the fact that no global standards exist for disclosure. With ever-changing global regulations, new requirements on the rise and the threat of monetary penalties, study sponsors are [\u2026]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/\" \/>\n<meta property=\"og:site_name\" content=\"Myanmar News Gazette\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-30T13:04:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ci4.googleusercontent.com\/proxy\/lN_48uyNqiePPdrUva8xz2Rp6ilqfCwTMgXw8WNxdYWaO2JHlGBTalLBAj-NuWsw1ji1dosvNRP7YCoymcfj0ju748KemyrLKbOKupB9uCD_jgc46QJoY78lOVkqrYhmyCuSXiKjhfraGuExhD7Y3Epx6YFrk-M0byJFom19KSl4Hxcb=s0-d-e1-ft#https:\/\/ml.globenewswire.com\/media\/YmM3YzMwZDAtZWQzMy00NmFhLWI2OWMtMTg4ZjcxNDgzMjhkLTEwNDA3ODM=\/tiny\/Citeline.png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/myanmarnewsgazette.com\/#\/schema\/person\/c7e2b10e6a2fda5bcbb164cc7b208a0f\"},\"headline\":\"Citeline Launches TrialScope Intelligence,\u00a0Meeting the Growing Complexities of Clinical Trial Disclosure\",\"datePublished\":\"2023-03-30T13:04:42+00:00\",\"dateModified\":\"2023-03-30T13:04:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/\"},\"wordCount\":535,\"publisher\":{\"@id\":\"https:\/\/myanmarnewsgazette.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ci4.googleusercontent.com\/proxy\/lN_48uyNqiePPdrUva8xz2Rp6ilqfCwTMgXw8WNxdYWaO2JHlGBTalLBAj-NuWsw1ji1dosvNRP7YCoymcfj0ju748KemyrLKbOKupB9uCD_jgc46QJoY78lOVkqrYhmyCuSXiKjhfraGuExhD7Y3Epx6YFrk-M0byJFom19KSl4Hxcb=s0-d-e1-ft#https:\/\/ml.globenewswire.com\/media\/YmM3YzMwZDAtZWQzMy00NmFhLWI2OWMtMTg4ZjcxNDgzMjhkLTEwNDA3ODM=\/tiny\/Citeline.png\",\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/\",\"url\":\"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/\",\"name\":\"Citeline Launches TrialScope Intelligence,\u00a0Meeting the Growing Complexities of Clinical Trial Disclosure - Myanmar News Gazette\",\"isPartOf\":{\"@id\":\"https:\/\/myanmarnewsgazette.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ci4.googleusercontent.com\/proxy\/lN_48uyNqiePPdrUva8xz2Rp6ilqfCwTMgXw8WNxdYWaO2JHlGBTalLBAj-NuWsw1ji1dosvNRP7YCoymcfj0ju748KemyrLKbOKupB9uCD_jgc46QJoY78lOVkqrYhmyCuSXiKjhfraGuExhD7Y3Epx6YFrk-M0byJFom19KSl4Hxcb=s0-d-e1-ft#https:\/\/ml.globenewswire.com\/media\/YmM3YzMwZDAtZWQzMy00NmFhLWI2OWMtMTg4ZjcxNDgzMjhkLTEwNDA3ODM=\/tiny\/Citeline.png\",\"datePublished\":\"2023-03-30T13:04:42+00:00\",\"dateModified\":\"2023-03-30T13:04:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/#primaryimage\",\"url\":\"https:\/\/ci4.googleusercontent.com\/proxy\/lN_48uyNqiePPdrUva8xz2Rp6ilqfCwTMgXw8WNxdYWaO2JHlGBTalLBAj-NuWsw1ji1dosvNRP7YCoymcfj0ju748KemyrLKbOKupB9uCD_jgc46QJoY78lOVkqrYhmyCuSXiKjhfraGuExhD7Y3Epx6YFrk-M0byJFom19KSl4Hxcb=s0-d-e1-ft#https:\/\/ml.globenewswire.com\/media\/YmM3YzMwZDAtZWQzMy00NmFhLWI2OWMtMTg4ZjcxNDgzMjhkLTEwNDA3ODM=\/tiny\/Citeline.png\",\"contentUrl\":\"https:\/\/ci4.googleusercontent.com\/proxy\/lN_48uyNqiePPdrUva8xz2Rp6ilqfCwTMgXw8WNxdYWaO2JHlGBTalLBAj-NuWsw1ji1dosvNRP7YCoymcfj0ju748KemyrLKbOKupB9uCD_jgc46QJoY78lOVkqrYhmyCuSXiKjhfraGuExhD7Y3Epx6YFrk-M0byJFom19KSl4Hxcb=s0-d-e1-ft#https:\/\/ml.globenewswire.com\/media\/YmM3YzMwZDAtZWQzMy00NmFhLWI2OWMtMTg4ZjcxNDgzMjhkLTEwNDA3ODM=\/tiny\/Citeline.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/myanmarnewsgazette.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Citeline Launches TrialScope Intelligence,\u00a0Meeting the Growing Complexities of Clinical Trial Disclosure\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/myanmarnewsgazette.com\/#website\",\"url\":\"https:\/\/myanmarnewsgazette.com\/\",\"name\":\"Myanmar News Gazette\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/myanmarnewsgazette.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/myanmarnewsgazette.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/myanmarnewsgazette.com\/#organization\",\"name\":\"Myanmar News Gazette\",\"url\":\"https:\/\/myanmarnewsgazette.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/myanmarnewsgazette.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/myanmarnewsgazette.com\/wp-content\/uploads\/2022\/07\/Myanmar-logo.png\",\"contentUrl\":\"https:\/\/myanmarnewsgazette.com\/wp-content\/uploads\/2022\/07\/Myanmar-logo.png\",\"width\":200,\"height\":200,\"caption\":\"Myanmar News Gazette\"},\"image\":{\"@id\":\"https:\/\/myanmarnewsgazette.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/myanmarnewsgazette.com\/#\/schema\/person\/c7e2b10e6a2fda5bcbb164cc7b208a0f\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/myanmarnewsgazette.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\/\/myanmarnewsgazette.com\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Citeline Launches TrialScope Intelligence,\u00a0Meeting the Growing Complexities of Clinical Trial Disclosure - Myanmar News Gazette","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/","og_locale":"en_US","og_type":"article","og_title":"Citeline Launches TrialScope Intelligence,\u00a0Meeting the Growing Complexities of Clinical Trial Disclosure - Myanmar News Gazette","og_description":"NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) \u2014 Clinical trial disclosure compliance is challenging, whether a sponsor is registering five trials or 500 trials. Compounding the complexity is the fact that no global standards exist for disclosure. With ever-changing global regulations, new requirements on the rise and the threat of monetary penalties, study sponsors are [\u2026]","og_url":"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/","og_site_name":"Myanmar News Gazette","article_published_time":"2023-03-30T13:04:42+00:00","og_image":[{"url":"https:\/\/ci4.googleusercontent.com\/proxy\/lN_48uyNqiePPdrUva8xz2Rp6ilqfCwTMgXw8WNxdYWaO2JHlGBTalLBAj-NuWsw1ji1dosvNRP7YCoymcfj0ju748KemyrLKbOKupB9uCD_jgc46QJoY78lOVkqrYhmyCuSXiKjhfraGuExhD7Y3Epx6YFrk-M0byJFom19KSl4Hxcb=s0-d-e1-ft#https:\/\/ml.globenewswire.com\/media\/YmM3YzMwZDAtZWQzMy00NmFhLWI2OWMtMTg4ZjcxNDgzMjhkLTEwNDA3ODM=\/tiny\/Citeline.png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/#article","isPartOf":{"@id":"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/"},"author":{"name":"admin","@id":"https:\/\/myanmarnewsgazette.com\/#\/schema\/person\/c7e2b10e6a2fda5bcbb164cc7b208a0f"},"headline":"Citeline Launches TrialScope Intelligence,\u00a0Meeting the Growing Complexities of Clinical Trial Disclosure","datePublished":"2023-03-30T13:04:42+00:00","dateModified":"2023-03-30T13:04:42+00:00","mainEntityOfPage":{"@id":"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/"},"wordCount":535,"publisher":{"@id":"https:\/\/myanmarnewsgazette.com\/#organization"},"image":{"@id":"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/#primaryimage"},"thumbnailUrl":"https:\/\/ci4.googleusercontent.com\/proxy\/lN_48uyNqiePPdrUva8xz2Rp6ilqfCwTMgXw8WNxdYWaO2JHlGBTalLBAj-NuWsw1ji1dosvNRP7YCoymcfj0ju748KemyrLKbOKupB9uCD_jgc46QJoY78lOVkqrYhmyCuSXiKjhfraGuExhD7Y3Epx6YFrk-M0byJFom19KSl4Hxcb=s0-d-e1-ft#https:\/\/ml.globenewswire.com\/media\/YmM3YzMwZDAtZWQzMy00NmFhLWI2OWMtMTg4ZjcxNDgzMjhkLTEwNDA3ODM=\/tiny\/Citeline.png","articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/","url":"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/","name":"Citeline Launches TrialScope Intelligence,\u00a0Meeting the Growing Complexities of Clinical Trial Disclosure - Myanmar News Gazette","isPartOf":{"@id":"https:\/\/myanmarnewsgazette.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/#primaryimage"},"image":{"@id":"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/#primaryimage"},"thumbnailUrl":"https:\/\/ci4.googleusercontent.com\/proxy\/lN_48uyNqiePPdrUva8xz2Rp6ilqfCwTMgXw8WNxdYWaO2JHlGBTalLBAj-NuWsw1ji1dosvNRP7YCoymcfj0ju748KemyrLKbOKupB9uCD_jgc46QJoY78lOVkqrYhmyCuSXiKjhfraGuExhD7Y3Epx6YFrk-M0byJFom19KSl4Hxcb=s0-d-e1-ft#https:\/\/ml.globenewswire.com\/media\/YmM3YzMwZDAtZWQzMy00NmFhLWI2OWMtMTg4ZjcxNDgzMjhkLTEwNDA3ODM=\/tiny\/Citeline.png","datePublished":"2023-03-30T13:04:42+00:00","dateModified":"2023-03-30T13:04:42+00:00","breadcrumb":{"@id":"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/#primaryimage","url":"https:\/\/ci4.googleusercontent.com\/proxy\/lN_48uyNqiePPdrUva8xz2Rp6ilqfCwTMgXw8WNxdYWaO2JHlGBTalLBAj-NuWsw1ji1dosvNRP7YCoymcfj0ju748KemyrLKbOKupB9uCD_jgc46QJoY78lOVkqrYhmyCuSXiKjhfraGuExhD7Y3Epx6YFrk-M0byJFom19KSl4Hxcb=s0-d-e1-ft#https:\/\/ml.globenewswire.com\/media\/YmM3YzMwZDAtZWQzMy00NmFhLWI2OWMtMTg4ZjcxNDgzMjhkLTEwNDA3ODM=\/tiny\/Citeline.png","contentUrl":"https:\/\/ci4.googleusercontent.com\/proxy\/lN_48uyNqiePPdrUva8xz2Rp6ilqfCwTMgXw8WNxdYWaO2JHlGBTalLBAj-NuWsw1ji1dosvNRP7YCoymcfj0ju748KemyrLKbOKupB9uCD_jgc46QJoY78lOVkqrYhmyCuSXiKjhfraGuExhD7Y3Epx6YFrk-M0byJFom19KSl4Hxcb=s0-d-e1-ft#https:\/\/ml.globenewswire.com\/media\/YmM3YzMwZDAtZWQzMy00NmFhLWI2OWMtMTg4ZjcxNDgzMjhkLTEwNDA3ODM=\/tiny\/Citeline.png"},{"@type":"BreadcrumbList","@id":"https:\/\/myanmarnewsgazette.com\/citeline-launches-trialscope-intelligence-meeting-the-growing-complexities-of-clinical-trial-disclosure\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/myanmarnewsgazette.com\/"},{"@type":"ListItem","position":2,"name":"Citeline Launches TrialScope Intelligence,\u00a0Meeting the Growing Complexities of Clinical Trial Disclosure"}]},{"@type":"WebSite","@id":"https:\/\/myanmarnewsgazette.com\/#website","url":"https:\/\/myanmarnewsgazette.com\/","name":"Myanmar News Gazette","description":"","publisher":{"@id":"https:\/\/myanmarnewsgazette.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/myanmarnewsgazette.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/myanmarnewsgazette.com\/#organization","name":"Myanmar News Gazette","url":"https:\/\/myanmarnewsgazette.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/myanmarnewsgazette.com\/#\/schema\/logo\/image\/","url":"https:\/\/myanmarnewsgazette.com\/wp-content\/uploads\/2022\/07\/Myanmar-logo.png","contentUrl":"https:\/\/myanmarnewsgazette.com\/wp-content\/uploads\/2022\/07\/Myanmar-logo.png","width":200,"height":200,"caption":"Myanmar News Gazette"},"image":{"@id":"https:\/\/myanmarnewsgazette.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/myanmarnewsgazette.com\/#\/schema\/person\/c7e2b10e6a2fda5bcbb164cc7b208a0f","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/myanmarnewsgazette.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/myanmarnewsgazette.com\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/myanmarnewsgazette.com\/wp-json\/wp\/v2\/posts\/34469"}],"collection":[{"href":"https:\/\/myanmarnewsgazette.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myanmarnewsgazette.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myanmarnewsgazette.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myanmarnewsgazette.com\/wp-json\/wp\/v2\/comments?post=34469"}],"version-history":[{"count":0,"href":"https:\/\/myanmarnewsgazette.com\/wp-json\/wp\/v2\/posts\/34469\/revisions"}],"wp:attachment":[{"href":"https:\/\/myanmarnewsgazette.com\/wp-json\/wp\/v2\/media?parent=34469"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myanmarnewsgazette.com\/wp-json\/wp\/v2\/categories?post=34469"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myanmarnewsgazette.com\/wp-json\/wp\/v2\/tags?post=34469"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}